p53 is often referred to as the 'guardian of the genome' due to its role in maintaining the integrity of cellular DNA. In dogs, this protein helps control the cell cycle, meaning it can halt the division of cells that may be damaged or at risk of becoming cancerous. By doing so, p53 is instrumental in preventing the development of tumors, which are unfortunately a common concern as dogs age. Understanding how p53 functions can provide insights into aging and the potential to enhance longevity through various interventions. As dogs grow older, the likelihood of age-related diseases, including cancer, increases. Research in geroscience has shown that enhancing the activity of p53 could lead to better cellular health and longevity. By potentially improving the pathways associated with p53, new veterinary longevity approaches aim to not only extend the lifespan of dogs but also improve their quality of life during their later years. This area of study is particularly exciting for dog owners who want to keep their furry companions healthy and active for as long as possible.
GLOSSARY
p53
p53 is a crucial protein that regulates the cell cycle and acts as a tumor suppressor, playing a vital role in preventing cancer in dogs and other animals.
Why it matters
Understanding p53's role in cellular health can help dog owners make informed choices about their pets' health and longevity.
Join thousands of owners on the waitlist
No spam, unsubscribe in one click.
Keep exploring
glossaryGlossary: RapamycinglossaryGlossary: Yamanaka factorsnewsPre-launch dossier: what we know about the canine longevity pill in 2026breedWirehaired Pointing Griffon longevity briefcountryPill watch: SerbiablogHow rapamycin moved from research curiosity to canine clinicbreedWorking Kelpie longevity briefblogWhat the Dog Aging Project taught us about real-world lifespanglossaryGlossary: ProteostasisnewsGeroscience consortium adds three more breeds to dose-finding studybreedHokkaido longevity briefnewsEU agency confirms it will publish a guidance document this quarter